Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hyperhomocysteinemia in chronic renal failure patients: relation to nutritional status and cardiovascular disease.

Clinical chemistry and laboratory medicine - 1 Aug 2001

Suliman M E, Lindholm B, Bárány P, Bergström J

Abstract excerpt

A moderate increase in plasma total homocysteine (tHcy) is considered to be an independent risk factor for cardiovascular disease (CVD) in the general population. Almost all chronic renal failure (CRF) patients have plasma concentration of tHcy that is elevated 3 to 4 times above normal. The prevalence of CVD, diabetes mellitus, malnutrition and hypoalbuminemia is high in CRF patients. Previous investigations...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Diseases
Share to Diabetes Mellitus

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Homocysteine

Share to Hyperhomocysteinemia

Share to Models, Chemical

Share to Mutation

Share to Renal Insufficiency

Share to Serum Albumin

Source

Identifiers

PMID: 11592443
DOI: 10.1515/CCLM.2001.122

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hyperhomocysteinemia in chronic renal failure patients: relation to nutritional status and cardiovascular disease.PMID 11592443Read ↗

Plasma homocysteine concentration in children with chronic renal failure.Semantic proximity Read ↗

Hyperhomocysteinemia is related to residual glomerular filtration and folate, but not to methylenetetrahydrofolate-reductase and methionine synthase polymorphisms, in supplemented end-stage renal disease patients undergoing hemodialysis.Semantic proximity Read ↗

Hyperhomocysteinemia, diabetes mellitus, and carotid atherosclerosis independently increase atherosclerotic vascular disease outcome in Japanese patients with end-stage renal disease.Semantic proximity Read ↗

Homocysteine, folate, vitamin B12 levels, and C677T MTHFR mutation in children with renal failure.Semantic proximity Read ↗

[Risk factors for atherosclerotic vascular disease in patients on maintenance hemodialysis--with especial respect to reverse cholesterol transport system and hyperhomocysteinemia].Semantic proximity Read ↗

Homocysteine, vitamin B12, serum and erythrocyte folate in peritoneal dialysis patients.Semantic proximity Read ↗

An MTHFR variant, homocysteine, and cardiovascular comorbidity in renal disease.Semantic proximity Read ↗

The common mutations C677T and A1298C in the human methylenetetrahydrofolate reductase gene are associated with hyperhomocysteinemia and cardiovascular disease in hemodialysis patients.Semantic proximity Read ↗

Correlates of total homocysteine plasma concentration in type 2 diabetes.Semantic proximity Read ↗

Homocysteine, malondialdehyde and endothelial markers in dialysis patients during low-dose folinic acid therapy.Semantic proximity Read ↗

Hyperhomocysteinaemia, folate and vitamin B12 in unsupplemented haemodialysis patients: effect of oral therapy with folic acid and vitamin B12.Semantic proximity Read ↗

Riboflavin is a determinant of total homocysteine plasma concentrations in end-stage renal disease patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.